儿童拔管失败与非侵入性呼吸支持使用的当代趋势
结果显示拔管后非侵入性呼吸支持使用近乎翻倍(20.9%升至39.9%),48小时内拔管失败率略降(8.9%降至8.1%),拔管失败与住院时间延长相关但与调整后死亡率无关。
要点
- 拔管后非侵入性呼吸支持使用从20.9%增至39.9%,拔管失败率小幅下降。
- 年龄<6周、肾脏/呼吸/心脏原发病及有创通气≥7天者拔管失败风险更高。
- 拔管失败延长机械通气、PICU及住院时间,但未增加调整后死亡率。
核心结论
- 过去十年拔管后非侵入性呼吸支持使用近乎翻倍,再插管风险约降低10%。
- 高危组可能获益,但低危组可能存在过度使用。
- 拔管失败与并发症相关,但与调整后全因死亡率无关。
研究设计与样本
- 回顾性横断面研究,数据来自Virtual Pediatric Intensive Care, LLC质量改进数据库158个北美中心。
主要发现
- 总体拔管失败率为8.5%。
- 拔管后非侵入性呼吸支持使用2013年20.9%、2022年39.9%(RR 1.90,95%CI 1.83-1.98,P<.01)。
- 48小时内拔管失败率8.9% vs 8.1%(RR 0.92,95%CI 0.85-0.99,P=.03);7天内12.3% vs 11.0%(RR 0.89,95%CI 0.83-0.95,P<.01)。
- 拔管失败与机械通气时长(11.6天 vs 4.0天)、PICU住院日(18.8天 vs 7.9天)、住院日(31.0天 vs 15.0天)延长相关(P<.01)。
- 全因风险调整死亡率8.5% vs 8.6%(RR 1.16,95%CI 0.97-1.38,P=.73)。
关键数值与推荐
- 年龄<6周OR 1.39(95%CI 1.31-1.47);6周至12个月OR 1.24(95%CI 1.18-1.30)(P<.01)。
- 肾脏原发病OR 1.25(95%CI 1.04-1.48,P=.01);呼吸诊断OR 1.15(95%CI 1.07-1.23,P<.01);心脏诊断OR 1.10(95%CI 1.04-1.16,P<.01)。
- 拔管前有创通气≥7天OR 1.26(95%CI 1.21-1.32,P<.01)。
- 0或1个危险因素者拔管失败率随时间无变化。
临床怎么用
- 对具备高危因素患儿应加强拔管前评估与拔管后监测。
- 低危患儿拔管后非侵入性呼吸支持需权衡过度使用风险。
- 拔管失败延长住院时间,应作为质量改进监测指标。
局限性
- 回顾性研究设计,来自质量改进数据库。
- 原文未报告各中心具体操作方案差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prolonged invasive mechanical ventilation (IMV) is associated with morbidity and mortality in children. Timely extubation is essential and must balance the competing risks of extubation failure (EF) and prolonged use of noninvasive respiratory support after extubation. RESEARCH QUESTION: Did EF risk factors, EF rates, noninvasive respiratory support after extubation practices, and patient-centered outcomes changed between 2013 and 2022? STUDY DESIGN AND METHODS: Retrospective cross-sectional study of patients younger than 19 years receiving IMV for ≥ 24 hours and extubated between 2013 and 2022 from 158 North American sites in the Virtual Pediatric Intensive Care, LLC, quality improvement database. RESULTS: One hundred thirty-two thousand seven hundred twelve unique encounters were included. The overall EF rate was 8.5%. Postextubation noninvasive respiratory support use nearly doubled (2013 vs 2022: 20.9% vs 39.9%; relative risk [RR], 1.90 [95% CI, 1.83-1.98]; P < .01), whereas EF decreased slightly (≤ 48 hours: 8.9% vs 8.1%; RR, 0.92 [95% CI, 0.85-0.99]; P = .03; ≤ 7 days: 12.3% vs 11.0%; RR, 0.89 [95% CI, 0.83-0.95]; P < .01). Logistic regression identified increased odds of EF associated with younger age (< 6 weeks: OR, 1.39 [95% CI, 1.31-1.47]; P < .01; 6 weeks-12 months: OR, 1.24 [95% CI, 1.18-1.30]; P < .01), primary renal diagnosis (OR, 1.25 [95% CI, 1.04-1.48]; P = .01), respiratory diagnosis (OR, 1.15 [95% CI, 1.07-1.23]; P < .01), and cardiac diagnosis (OR, 1.10 [95% CI, 1.04-1.16]; P < .01), and ≥ 7 days of invasive ventilation before extubation (OR, 1.26 [95% CI, 1.21-1.32]; P < .01). EF rates were unchanged over time for patients with 0 or 1 risk factor. EF was associated with longer mechanical ventilation duration (11.6 days vs 4.0 days; P < .01), longer pediatric ICU length of stay (18.8 days vs 7.9 days; P < .01), and longer hospital length of stay (31.0 days vs 15.0 days; P < .01), but not with all-cause risk-adjusted mortality (8.5% vs 8.6%; RR, 1.16 [95% CI, 0.97-1.38]; P = .73). INTERPRETATION: Our results demonstrate that in the last decade, noninvasive respiratory support after extubation has nearly doubled, with an approximately 10% reintubation risk reduction. High-risk groups may benefit, but overuse may exist in low-risk groups with respect to EF. EF is associated with morbidity, but not increased mortality.
引用
- Loberger JM, Moore M, Scanlon M, et al. Contemporary Trends in Pediatric Extubation Failure and Noninvasive Respiratory Support Use. Chest. 2025. PMID: 40818775. doi:10.1016/j.chest.2025.07.4080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。